This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a fluorinated pyrrolidine ring and a benzyl group, makes it a valuable intermediate for designing molecules with potential biological activity. It is often employed in the creation of compounds targeting central nervous system disorders, such as depression, anxiety, or neurodegenerative diseases, due to its ability to influence receptor interactions. Additionally, its ester group allows for further chemical modifications, enabling the development of prodrugs or active pharmaceutical ingredients with improved bioavailability or stability. Researchers also explore its use in medicinal chemistry for optimizing pharmacokinetic properties or enhancing selectivity toward specific biological targets.